Medical Robotics Market

Growing applications of medical robotics in healthcare fuels market growth

Surgical robotics has emerged as a new growth point and technological incubator in modern surgery. Robot-assisted surgeries were developed to augment the capabilities of surgeons while performing open surgeries on a patient or to address the limits of existing minimally invasive surgery technologies. 

Minimally invasive surgery with surgical robotics aids in reducing recovery time, accelerating healing, and in avoiding scarring. The increased need for minimally invasive surgical treatments, as well as the use of medical robotics in helping surgical procedures, have significantly improved the efficacy of surgical operations. Therefore, the above-mentioned factors are promoting market growth.

Furthermore, the number of prescriptions filled for American adults and children rose by 85%, from 2.4 billion to 4.5 billion a year, between 1997 and 2016. The rising incidence of medication errors, particularly dispensing errors in hospitals and retail pharmacies, is a burden on pharmacists and driving demand for medical robotics for automating the dispensing process. According to the data published by Enliven Health in July 2020, medication errors harm at least 1.5 million people, and around 7,000-9,000 people die due to medication errors per year in the US.

By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. The North America medical robotics market accounted for the largest market share in 2022. Key factors attributed to it are the increasing efficiency of medical robots in performing tasks that include surgeries in the geriatric population and mounting cases of trauma injuries are some of the major factors driving the growth of the medical robotics market in the region.

Further, the major countries will be study are: The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: MEDICAL ROBOTICS MARKET BY REGION 2022 & 2032 (USD Billion)

Europe medical robotics market accounted for the second-largest market share due to increasing geriatric population in the developed countries and the globalization of healthcare. Furthermore, the Germany medical robotics market attributed to hold the largest market share, and the France medical robotics market is projected be the fastest growing market in the Europe region.

The Asia-Pacific medical robotics market is expected to be the fastest growing from 2024 to 2032 due to the rising geriatric population and the rise in the demand for minimally invasive and non-invasive surgical procedures. rising geriatric population and the rise in the demand for minimally invasive and non-invasive surgical procedures. Moreover, China medical robotics market accounted to hold the largest market share, and the India medical robotics market is projected to be the fastest growing market in the Asia-Pacific region.

Despite several market drivers having a significant impact on market growth, the growth projectile of market players is dependent on market conditions, government assistance, and industry development. However, the market is highly competitive, with well-established companies, well-defined market entry channels, and a robust product innovation pipeline. Several industry participants are introducing products to differentiate themselves in this competitive market.

Auris Health Inc. (Auris) is a leading company that develops minimally invasive techniques. Moreover, the company transforms medical intervention by integrating robotics, micro-instrumentation, endoscope design, sensing, and data science into one platform. Additionally, Auris Health was acquired by Ethicon (a subsidiary of Johnson & Johnson Services, Inc.) in 2019 to expand its digital surgery portfolio. The company has a global presence in more than 170 countries worldwide.

Moreover, In May 2022, Ethicon's monarch received FDA approval for urology procedures. Initially, the monarch was only used for bronchoscopy.